JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.

Clinical trial NCT07284134 · RECRUITING

Trial details

NCT number: NCT07284134
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Start date: 2025-12-24
Primary completion: 2027-10-13
Enrollment: 560

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.